Rifampin. Levels in serum and saliva and effect on the meningococcal carrier state.
D000284:Administration, Oral; D002353:Carrier State / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006801:Humans; D008589:Meningococcal Infections / Q000188:drug therapy*; D009345:Neisseria meningitidis / Q000187:drug effects / Q000302:isolation & purification; D010919:Placebos; D012293:Rifampin / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D012463:Saliva / Q000032:analysis; D013411:Sulfadiazine / Q000494:pharmacology
D010919:Placebos; D013411:Sulfadiazine; D012293:Rifampin